摘要
红参为珍贵的药材,已有1000多年的历史,遍及中国、韩国、日本等亚洲国家。韩国红参(korean red ginseng,KRG)不仅是滋补品,也是用于治疗免疫疾病、肝病、癌症等疾病的传统药材。KRG含有多种人参皂苷、糖类、微量元素等成分,具有较高的药用价值,韩国各机构对其进行了较深入的研究,近5年在美国《科学引文索引》上发表文章数百篇。目前实验研究主要集中在红参有效成分的筛选及其药理作用,临床研究以单方制剂为主。笔者通过查阅KRG相关文献,从增强免疫、抗疲劳、抗衰老、抗氧化、调节糖脂代谢、抗炎、抗肿瘤以及在多个系统疾病中的运用等多方面对其药理作用进行了概述,为KRG的进一步研究与临床应用提供依据。
Red ginseng is a precious medicine.It is more than 1,000 years old and popularized in China,South Korea,Japan and other Asian countries.Korean Red ginseng(KRG)is not only a tonic but also a traditional medicine for the treatment of immune diseases,liver diseases,cancer and other diseases.KRG contains a variety of ginseng saponins,glucoside,trace elements and other components and it has high medicinal value.It has been deeply studied by various South Korean research institutions,and hundreds of articles were published in Science Citation Index journals in the last 5 years.Current experimental research mainly focuses on Red ginseng extract,polysaccharide,diol saponin,and non-saponin part,clinical studies are mainly composed of unilateral preparations.By consulting the relevant literature on KRG,and summarizing its pharmacological effects from many aspects of enhanced immunity,anti-fatigue,anti-aging,antioxidant,regulating glycolipid metabolism,anti-inflammatory,anti-tumor,and application in multiple systemic diseases,this paper was aim to provide a basis for further research and clinical application of KRG.
作者
李代均
孙永康
王新志
LI Daijun;SUN Yongkang;WANG Xinzhi(Henan University of Chinese Medicine,Zhengzhou 450046,China;The First Affiliated Hospital of Henan University of Traditional Chinese Medicine,Zhengzhou 450000,China)
出处
《中国中医基础医学杂志》
CAS
CSCD
北大核心
2023年第4期625-630,共6页
JOURNAL OF BASIC CHINESE MEDICINE
基金
国家中医药管理局中医药领军人才支持计划(国中医药人教发[2018]284号)-王新志岐黄学者项目
全国名老中医药专家传承工作室建设项目(豫中医科教[2017]5号)-王新志全国名老中医药专家传承工作室。
关键词
红参
韩国红参
红参提取物
药理作用
研究进展
Red ginseng
Korean Red ginseng
Red ginseng extract
Pharmacological effect
Research progress
